Stock Events

Stock Events

Guardant Health 

$145.55
159
-$23.79-14.05%Friday 08:17

Statistics

Day High
145.55
Day Low
141.05
52W High
187.22
52W Low
87.6
Volume
29,046
Avg. Volume
-
Mkt Cap
19.53B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-1
-0.91
-0.83
-0.74
Expected EPS
-0.75
Actual EPS
N/A

Financials

-42.39%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
982.02MRevenue
-416.28MNet Income

Analyst Ratings

$198.15Average Price Target
The highest estimate is ⁦225.00⁩.
From 20 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GH.BOATS. It's not an investment recommendation.
NVIDIA
34
NVDA
Alphabet
32
GOOGL
Amazon
28
AMZN
AMD
28
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina provides genomic sequencing solutions and competes directly in the precision medicine space, offering technologies that overlap with Guardant Health's cancer detection and treatment monitoring services.
Fulgent Genetics
FLGT
Mkt Cap567.37M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the genomic and molecular diagnostics space with Guardant Health.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences offers sequencing systems that compete in the broader market of genomic analysis, including applications in cancer research and diagnostics.
Bionano Genomics
BNGO
Mkt Cap16.07M
Bionano Genomics provides tools for genomic analysis, including structural variant detection that can be applied in cancer research, competing in the genomics space.
Myriad Genetics
MYGN
Mkt Cap607.38M
Myriad Genetics offers genetic testing and precision medicine solutions, including for cancer, competing with Guardant Health in the personalized healthcare market.
Qiagen NV
QGEN
Mkt Cap10.37B
Qiagen provides sample and assay technologies for molecular diagnostics, including cancer, competing in the field of precision medicine and diagnostics.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific offers a broad range of solutions for genetic analysis and diagnostics, including cancer, competing with Guardant Health in the life sciences and healthcare sectors.

About

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Show More
CEO
ISIN
US40131M1099

Listings

MI
IT
1GH.MI
STU
DE
5GH.STU
MU
DE
5GH.MU
F
DE
5GH.F

0 Comments

Share your thoughts

FAQs

What is Guardant Health stock price today?▼
The current price of GH.BOATS is $145.55 USD — it has decreased by -14.05% in the past 24 hours. Watch Guardant Health stock price performance more closely on the chart.
What is Guardant Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Guardant Health stocks are traded under the ticker GH.BOATS.
What is Guardant Health market cap?▼
Today Guardant Health has the market capitalization of 19.53B
When is the next Guardant Health earnings date?▼
Guardant Health is going to release the next earnings report on February 25, 2027.
What is Guardant Health revenue for the last year?▼
Guardant Health revenue for the last year amounts to 982.02M USD.
What is Guardant Health net income for the last year?▼
GH.BOATS net income for the last year is -416.28M USD.
In which sector is Guardant Health located?▼
Guardant Health operates in the Other sector.
When did Guardant Health complete a stock split?▼
Guardant Health has not had any recent stock splits.